FDA Warning Letter — Osborne Bi-Rite 14

Case 694173 — FEI 3032448004

The FDA took a Warning Letter action against Osborne Bi-Rite 14 on Oct 3, 2024 (Nashville, TN). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Osborne Bi-Rite 14
Date
Oct 3, 2024
Fiscal Year
2025
Product Type
Tobacco
Center
CTP
Location
Nashville, TN (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.